Correlation Between Nuvectis Pharma and Karuna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Karuna Therapeutics, you can compare the effects of market volatilities on Nuvectis Pharma and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Karuna Therapeutics.
Diversification Opportunities for Nuvectis Pharma and Karuna Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Nuvectis and Karuna is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Karuna Therapeutics go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and Karuna Therapeutics
If you would invest 20,311 in Karuna Therapeutics on September 6, 2024 and sell it today you would earn a total of 0.00 from holding Karuna Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 4.55% |
Values | Daily Returns |
Nuvectis Pharma vs. Karuna Therapeutics
Performance |
Timeline |
Nuvectis Pharma |
Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvectis Pharma and Karuna Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvectis Pharma and Karuna Therapeutics
The main advantage of trading using opposite Nuvectis Pharma and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Transaction History View history of all your transactions and understand their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |